Olgu Sunumu

Primary Active Epstein-Barr Virus Infection Coexisting with Immune Thrombocytopenia in Children-A Rare Trigger Factor of Immun Thrombocytopenia: Two Case Reports

Cilt: 11 Sayı: 1 27 Mart 2024
Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi Kapak
Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
PDF İndir
EN TR

Primary Active Epstein-Barr Virus Infection Coexisting with Immune Thrombocytopenia in Children-A Rare Trigger Factor of Immun Thrombocytopenia: Two Case Reports

Öz

Immune thrombocytopenia (ITP) is a reason of thrombocytopenia that is characterized by isolated thrombocytopenia in childhood. Epstein barr virus infection (EBV) is a mildly and uncomplicated ailment that might be a trigger factor for ITP. Here, we discuss two cases with ITP secondary Epstein barr virus infection.

Anahtar Kelimeler

Destekleyen Kurum

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Etik Beyan

Informed Consent: Informed consent was taken prior to writing this case report from the patient’s parents.

Kaynakça

  1. 1. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113:2386–2393.
  2. 2. Correia S, Bridges R, Wegner F, et al. Sequence Variation of Epstein-Barr Virus: Viral Types, Geography, Codon Usage, and Diseases. J Virol 2018; 92: e01132-18.
  3. 3. Pipp ML, Means ND, Sixbey JW, Morris KL, Gue CL, Baddour LM. Acute Epstein- Barr virus infection complicated by severe thrombocytopenia. Clin Infect Dis 1997; 25:1237–9.
  4. 4. Zeller B, Rajantie J, Hedlund-Treutiger I, et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr 2005; 94:178-84.
  5. 5. Chiang MR, Wei CC, Muo CS, Fu LS, Li TC, Kao CH. Association of primary immune thrombocytopenia and common allergic diseases among children. Pediatr Res 2015; 77:597-601.
  6. 6. Ebell MH. Epstein-Barr virus infectious mononucleosis. Am Fam Physician 2004; 70:1279-87.
  7. 7. Elalfy MS, Nugent D. Viruses, anti-viral therapy, and viral vaccines in children with immune thrombocytopenia. Semin Hematol 2016; 53:70-72.
  8. 8. Nielsen TR, Rostgaard K, Nielsen NM, et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol 2007; 64:72-75.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri (Diğer)

Bölüm

Olgu Sunumu

Yazarlar

Yayımlanma Tarihi

27 Mart 2024

Gönderilme Tarihi

8 Şubat 2024

Kabul Tarihi

25 Mart 2024

Yayımlandığı Sayı

Yıl 2024 Cilt: 11 Sayı: 1

DOI

https://doi.org/10.34087/cbusbed.1433575

IZ

https://izlik.org/JA93AZ76LK

Kaynak Göster

RIS / Bibtex
APA
Gökçe, Ş., Tosyalı, M., Şafaklı, A., Yıldırım, R., Koçer Ahmadov, N. B., Tunçalp, G., Bostancı, N., Mammadova, A., Çelebi, E. G., Şahin, N. N., Türksönmez, Ç., Erol, A., Köse, H. O., & Umay Koç, F. (2024). Primary Active Epstein-Barr Virus Infection Coexisting with Immune Thrombocytopenia in Children-A Rare Trigger Factor of Immun Thrombocytopenia: Two Case Reports. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 11(1), 183-186. https://doi.org/10.34087/cbusbed.1433575
AMA
1.Gökçe Ş, Tosyalı M, Şafaklı A, vd. Primary Active Epstein-Barr Virus Infection Coexisting with Immune Thrombocytopenia in Children-A Rare Trigger Factor of Immun Thrombocytopenia: Two Case Reports. CBU-SBED. 2024;11(1):183-186. doi:10.34087/cbusbed.1433575
Chicago
Gökçe, Şule, Merve Tosyalı, Aykut Şafaklı, vd. 2024. “Primary Active Epstein-Barr Virus Infection Coexisting with Immune Thrombocytopenia in Children-A Rare Trigger Factor of Immun Thrombocytopenia: Two Case Reports”. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 11 (1): 183-86. https://doi.org/10.34087/cbusbed.1433575.
EndNote
Gökçe Ş, Tosyalı M, Şafaklı A, Yıldırım R, Koçer Ahmadov NB, Tunçalp G, Bostancı N, Mammadova A, Çelebi EG, Şahin NN, Türksönmez Ç, Erol A, Köse HO, Umay Koç F (01 Mart 2024) Primary Active Epstein-Barr Virus Infection Coexisting with Immune Thrombocytopenia in Children-A Rare Trigger Factor of Immun Thrombocytopenia: Two Case Reports. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 11 1 183–186.
IEEE
[1]Ş. Gökçe vd., “Primary Active Epstein-Barr Virus Infection Coexisting with Immune Thrombocytopenia in Children-A Rare Trigger Factor of Immun Thrombocytopenia: Two Case Reports”, CBU-SBED, c. 11, sy 1, ss. 183–186, Mar. 2024, doi: 10.34087/cbusbed.1433575.
ISNAD
Gökçe, Şule - Tosyalı, Merve - Şafaklı, Aykut - Yıldırım, Rıza - Koçer Ahmadov, Necla Burcu - Tunçalp, Gizem - Bostancı, Nur v.dğr. “Primary Active Epstein-Barr Virus Infection Coexisting with Immune Thrombocytopenia in Children-A Rare Trigger Factor of Immun Thrombocytopenia: Two Case Reports”. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 11/1 (01 Mart 2024): 183-186. https://doi.org/10.34087/cbusbed.1433575.
JAMA
1.Gökçe Ş, Tosyalı M, Şafaklı A, Yıldırım R, Koçer Ahmadov NB, Tunçalp G, Bostancı N, Mammadova A, Çelebi EG, Şahin NN, Türksönmez Ç, Erol A, Köse HO, Umay Koç F. Primary Active Epstein-Barr Virus Infection Coexisting with Immune Thrombocytopenia in Children-A Rare Trigger Factor of Immun Thrombocytopenia: Two Case Reports. CBU-SBED. 2024;11:183–186.
MLA
Gökçe, Şule, vd. “Primary Active Epstein-Barr Virus Infection Coexisting with Immune Thrombocytopenia in Children-A Rare Trigger Factor of Immun Thrombocytopenia: Two Case Reports”. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, c. 11, sy 1, Mart 2024, ss. 183-6, doi:10.34087/cbusbed.1433575.
Vancouver
1.Şule Gökçe, Merve Tosyalı, Aykut Şafaklı, Rıza Yıldırım, Necla Burcu Koçer Ahmadov, Gizem Tunçalp, Nur Bostancı, Ayla Mammadova, Elif Gökçe Çelebi, Nida Nur Şahin, Çağla Türksönmez, Aylin Erol, Hüseyin Orkun Köse, Feyza Umay Koç. Primary Active Epstein-Barr Virus Infection Coexisting with Immune Thrombocytopenia in Children-A Rare Trigger Factor of Immun Thrombocytopenia: Two Case Reports. CBU-SBED. 01 Mart 2024;11(1):183-6. doi:10.34087/cbusbed.1433575